Cadena-Nava RD - Search Results

1

Biocatalytic virus capsid as nanovehicle for enzymatic activation of Tamoxifen in tumor cells.

Tapia-Moreno A, Juarez-Moreno K, Gonzalez-Davis O, Cadena-Nava RD, Vazquez-Duhalt R. Tapia-Moreno A, et al. Biotechnol J. 2017 Jun;12(6). doi: 10.1002/biot.201600706. Epub 2017 May 9. Biotechnol J. 2017. PMID: 28371407

2

Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450.

Sánchez-Sánchez L, Cadena-Nava RD, Palomares LA, Ruiz-Garcia J, Koay MS, Cornelissen JJ, Vazquez-Duhalt R. Sánchez-Sánchez L, et al. Enzyme Microb Technol. 2014 Jun 10;60:24-31. doi: 10.1016/j.enzmictec.2014.04.003. Epub 2014 Apr 13. Enzyme Microb Technol. 2014. PMID: 24835096

3

Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery.

Sánchez-Sánchez L, Tapia-Moreno A, Juarez-Moreno K, Patterson DP, Cadena-Nava RD, Douglas T, Vazquez-Duhalt R. Sánchez-Sánchez L, et al. J Nanobiotechnology. 2015 Oct 9;13:66. doi: 10.1186/s12951-015-0127-z. J Nanobiotechnology. 2015. PMID: 26452461 Free PMC article.

4

Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes.

Nuñez-Rivera A, Fournier PGJ, Arellano DL, Rodriguez-Hernandez AG, Vazquez-Duhalt R, Cadena-Nava RD. Nuñez-Rivera A, et al. Beilstein J Nanotechnol. 2020 Feb 20;11:372-382. doi: 10.3762/bjnano.11.28. eCollection 2020. Beilstein J Nanotechnol. 2020. PMID: 32175217 Free PMC article.

5

Virus-Based Nanoreactors with GALT Activity for Classic Galactosemia Therapy.

Gama P, Cadena-Nava RD, Juarez-Moreno K, Pérez-Robles J, Vazquez-Duhalt R. Gama P, et al. ChemMedChem. 2021 May 6;16(9):1438-1445. doi: 10.1002/cmdc.202000999. Epub 2021 Feb 17. ChemMedChem. 2021. PMID: 33595183

6

Targeted Enzymatic VLP-Nanoreactors with β-Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's Disease.

Chauhan K, Olivares-Medina CN, Villagrana-Escareño MV, Juárez-Moreno K, Cadena-Nava RD, Rodríguez-Hernández AG, Vazquez-Duhalt R. Chauhan K, et al. Among authors: cadena nava rd. ChemMedChem. 2022 Oct 6;17(19):e202200384. doi: 10.1002/cmdc.202200384. Epub 2022 Aug 23. ChemMedChem. 2022. PMID: 35918294 Free PMC article.

7

Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment.

Díaz-Barriga C, Villanueva-Flores F, Quester K, Zárate-Romero A, Cadena-Nava RD, Huerta-Saquero A. Díaz-Barriga C, et al. Pharmaceutics. 2021 Apr 22;13(5):604. doi: 10.3390/pharmaceutics13050604. Pharmaceutics. 2021. PMID: 33922106 Free PMC article.

8

Antiviral therapy in shrimp through plant virus VLP containing VP28 dsRNA against WSSV.

Ramos-Carreño S, Giffard-Mena I, Zamudio-Ocadiz JN, Nuñez-Rivera A, Valencia-Yañez R, Ruiz-Garcia J, Viana MT, Cadena-Nava RD. Ramos-Carreño S, et al. Beilstein J Org Chem. 2021 Jun 1;17:1360-1373. doi: 10.3762/bjoc.17.95. eCollection 2021. Beilstein J Org Chem. 2021. PMID: 34136015 Free PMC article.

9

Antimicrobial and Virus Adsorption Properties of Y-Zeolite Exchanged with Silver and Zinc Cations.

Sánchez-López P, Hernández-Hernández KA, Fuentes Moyado S, Cadena Nava RD, Smolentseva E. Sánchez-López P, et al. Among authors: cadena nava rd. ACS Omega. 2024 Feb 7;9(7):7554-7563. doi: 10.1021/acsomega.3c06462. eCollection 2024 Feb 20. ACS Omega. 2024. PMID: 38405448 Free PMC article.

10

Phase diagram of self-assembled viral capsid protein polymorphs.

Lavelle L, Gingery M, Phillips M, Gelbart WM, Knobler CM, Cadena-Nava RD, Vega-Acosta JR, Pinedo-Torres LA, Ruiz-Garcia J. Lavelle L, et al. J Phys Chem B. 2009 Mar 26;113(12):3813-9. doi: 10.1021/jp8079765. J Phys Chem B. 2009. PMID: 19673134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page